Stock Information
Syndax Pharmaceuticals Inc (SNDX)
Ticker Symbol: SNDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,185.91 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.3003
Revenue (TTM): $1.99 M
Dividend Yield: N/A%
ROE: -206.62%
Latest News
-
Barclays Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $37
Fri, May 1, 2026 11:34 AM
-
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2026 Earnings Call Transcript
Thu, Apr 30, 2026 10:51 PM
-
Transcript : Syndax Pharmaceuticals, Inc., Q1 2026 Earnings Call, Apr 30, 2026
Thu, Apr 30, 2026 10:35 PM
-
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Stock Slides After Q1 Revenue Misses Street Forecasts Despite 224% Growth
Thu, Apr 30, 2026 8:41 PM
-
Syndax Pharmaceuticals : SNDX 1Q26 Earnings Deck FINAL
Thu, Apr 30, 2026 8:08 PM
-
Syndax: Q1 Earnings Snapshot
Thu, Apr 30, 2026 4:24 PM
-
Syndax Reports First Quarter 2026 Financial Results and Provides Business Update
Thu, Apr 30, 2026 4:03 PM
-
Syndax Pharmaceuticals Q1 EPS $(0.48) Beats $(0.64) Estimate, Sales $64.864M Miss $70.439M Estimate
Thu, Apr 30, 2026 4:01 PM
-
Earnings Scheduled For April 30, 2026
Thu, Apr 30, 2026 7:11 AM
-
Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
Mon, Apr 27, 2026 7:05 AM
Key Financials
Financial data not available
